Covid-19: Oxford Vaccine Could Be Ready in September

Researchers believe the vaccine, which is in its third and final testing stage, is approximately 80 percent effective in preventing the severe form of the disease.

RIO DE JANEIRO, BRAZIL - Developed by Oxford University in partnership with pharmaceutical company AstraZeneca, the vaccine against Covid-19 could finalize its human trials in September, according to Sarah Gilbert, the scientist behind the studies at the British university.

The immunizer - considered the most advanced in the . . .

To read the full NEWS and much more, Subscribe to our Premium Membership Plan. Already Subscribed?